GGrantIndex
Sort

11,323 grants matching glioblastoma

Gene-specific transcriptional silencing by REST function

$318,933
Yan Jessie Zhang · University Of Texas At Austin · R01 · FY2020 · GM

MODULATION OF PRB2/P130 MEDIATED GROWTH SUPPRESSION

$318,868
Temple University · R01 · FY2001 · CA

OV Therapy Induced Changes in Tumor Secretome and Their Impact on Therapy

$318,750
Balveen Kaur · Ohio State University · R01 · FY2009 · NS

OV Therapy Induced Changes in Tumor Secretome and Their Impact on Therapy

$318,750
Balveen Kaur · Ohio State University · R01 · FY2008 · NS

Therapeutic modulation of angiogenesis in human gliomas

$318,638
Erwin G Van Meir · Emory University · R01 · FY2008 · CA

Phase II Study of 44Gy from 131I-81C6 for CNS Tumors

$318,620
Duke University · R21 · FY2003 · CA

HEF1 Coordination of Cell Cycle, Migration, and Invasion in Cancer

$318,618
Erica A Golemis · Research Inst Of Fox Chase Can Ctr · R01 · FY2011 · CA

Cellular Pharmacology of Rapamycin

$318,589
Gary G Chiang · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2007 · CA

Predictive Imaging Biomarkers for GBM Therapeutic Response and Recurrence

$318,460
Thomas L. Chenevert · University Of Michigan At Ann Arbor · P01 · FY2015 · CA

Project 4: Awakening immune responses to GBM by enhancing immune cell trafficking and activation with oHSV armed with Cetuximab-CCL5 and anti-CD47 antibody payloads.

$318,443
Michael A Caligiuri · Brigham And Women'S Hospital · P01 · FY2024 · CA

Polyketides via Redox-Triggered Alcohol C-H Functionalization

$318,423
Michael J Krische · University Of Texas At Austin · R01 · FY2024 · GM

Engineering stem cell therapies to understand and overcome glioblastoma adaption

$318,366
Shawn Hingtgen · Univ Of North Carolina Chapel Hill · R01 · FY2021 · NS

The Fn14 Receptor and Brain Tumor Invasion

$318,347
Jeffrey A Winkles · University Of Maryland Baltimore · R01 · FY2011 · NS

Measles Virotherapy and radiovirotherapy in the Treatment of recurrent gliomas

$318,329
Evanthia Galanis · Mayo Clinic Rochester · R01 · FY2014 · CA

Establishing the role of the atypical kinase ADCK3 in mitochondrial metabolism

$318,307
David J Pagliarini · Morgridge Institute For Research, Inc. · R01 · FY2017 · GM

Therapeutically Exploiting a Newly Isolated Neural-Like Stem Cell Against GSB

$318,276
Akiva Mintz · Columbia University Health Sciences · R01 · FY2018 · CA

Realizing the radiobiological impact of protons and high-LET particles in head and neck cancer and glioblastoma models

$318,154
Jason Parsons · University Of Birmingham · R01 · FY2024 · CA

Modulation of Resistance to antiangiogenic therapy: A clinical trial with correla

$318,015
John F De Groot · University Of Tx Md Anderson Can Ctr · R21 · FY2011 · CA

Transcriptional regulation of gliomagenesis

$318,015
Suyun Huang · University Of Tx Md Anderson Can Ctr · R01 · FY2014 · CA

Oncogene cooperation in glioma genesis

$318,015
Wei Zhang · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA

Regulatory T Cells and Oncolytic Virotherapy of Glioma

$318,015
Maciej S Lesniak · University Of Chicago · R01 · FY2013 · CA

Oncogene cooperation in glioma genesis

$318,015
Wei Zhang · University Of Tx Md Anderson Can Ctr · R01 · FY2011 · CA

Novel role of compensatory proliferation in human brain tumor

$317,924
Ichiro Nakano · University Of Alabama At Birmingham · R01 · FY2018 · CA

Establishing the role of the atypical kinase ADCK3 in mitochondrial metabolism

$317,905
David J Pagliarini · University Of Wisconsin-Madison · R01 · FY2014 · GM

Phase II Study of 44Gy from 131I-81C6 for CNS Tumors

$317,899
Duke University · R21 · FY2004 · CA